Ting Xu
Chief Executive Officer bei ALPHAMAB ONCOLOGY
Vermögen: 184 Mio $ am 31.03.2024
Profil
Gründer von Alphamab Oncology und Suzhou Alphamab Co. Ltd. ist Ting Xu derzeit Chairman, President & Chief Executive Officer bei Suzhou Alphamab Co. Ltd. sowie Direktor und Geschäftsführer bei Jiangsu Alphamab Biopharmaceuticals Co. Ltd (eine Tochtergesellschaft von Suzhou Alphamab Co. Ltd.), Chairman & Chief Executive Officer für Alphamab Oncology und Chairman für Suzhou SmartNuclide Biopharmaceutical Co. Ltd. Außerdem ist er Mitglied des Vorstands von Suzhou Bionovogene Biotech Co. Ltd., Shanghai Kangjing Bioscience Co. Ltd. und Suzhou Oncoimmune Co. Ltd. In der Vergangenheit war Ting Xu als Senior Scientist bei Biogen Idec, Inc. (North Carolina). Er erhielt einen Bachelor-Abschluss von der Universität Nanjing und einen Doktortitel sowie einen Hochschulabschluss von der Chinesischen Akademie der Wissenschaften.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALPHAMAB ONCOLOGY
33,02% | 30.06.2023 | 318 552 950 ( 33,02% ) | 184 Mio $ | 31.03.2024 |
Aktive Positionen von Ting Xu
| Unternehmen | Position | Beginn |
|---|---|---|
| ALPHAMAB ONCOLOGY | Chief Executive Officer | 01.10.2018 |
Suzhou Alphamab Co., Ltd.
 Suzhou Alphamab Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Alphamab Co. Ltd. operates as biotechnology company. It offers antibody screening, pharmacodynamics and protein/Ab engineering. The company was founded by Ting Xu in 2009 and is headquartered in Suzhou, China. | Founder | 01.11.2008 |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
 Jiangsu Alphamab Biopharmaceuticals Co., Ltd Pharmaceuticals: MajorHealth Technology Part of Suzhou Alphamab Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd is a private company that manufactures and distributes therapeutics for cancer treatment. Jiangsu Alphamab Biopharmaceuticals Co., Ltd is based in Suzhou, China. The Chinese company was founded in 2015 by Ting Xu. Ting Xu has been the CEO since 2015. | Chief Executive Officer | 01.01.2015 |
Suzhou SmartNuclide Biopharmaceutical Co., Ltd.
 Suzhou SmartNuclide Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Suzhou SmartNuclide Biopharmaceutical Co. Ltd. develops and manufactures radiopharmaceuticals. The company is based in Suzhou, China. | Founder | 01.01.2015 |
| Suzhou Bionovogene Biotech Co. Ltd. | Director/Board Member | - |
| Shanghai Kangjing Bioscience Co. Ltd. | Director/Board Member | - |
| Suzhou Oncoimmune Co. Ltd. | Director/Board Member | - |
Suzhou PANOMIX Biomedical Tech Co., Ltd.
 Suzhou PANOMIX Biomedical Tech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Panomik Biomedical Technology Co. Ltd. provides metabolomics testing and analysis services. The company is located in China. | Chairman | - |
Ehemalige bekannte Positionen von Ting Xu
| Unternehmen | Position | Ende |
|---|---|---|
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Corporate Officer/Principal | 01.01.2010 |
Ausbildung von Ting Xu
| Nanjing University | Undergraduate Degree |
| Chinese Academy of Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALPHAMAB ONCOLOGY | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Suzhou Alphamab Co., Ltd.
Suzhou Alphamab Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Alphamab Co. Ltd. operates as biotechnology company. It offers antibody screening, pharmacodynamics and protein/Ab engineering. The company was founded by Ting Xu in 2009 and is headquartered in Suzhou, China. | Commercial Services |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Jiangsu Alphamab Biopharmaceuticals Co., Ltd Pharmaceuticals: MajorHealth Technology Part of Suzhou Alphamab Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd is a private company that manufactures and distributes therapeutics for cancer treatment. Jiangsu Alphamab Biopharmaceuticals Co., Ltd is based in Suzhou, China. The Chinese company was founded in 2015 by Ting Xu. Ting Xu has been the CEO since 2015. | Health Technology |
Suzhou SmartNuclide Biopharmaceutical Co., Ltd.
Suzhou SmartNuclide Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Suzhou SmartNuclide Biopharmaceutical Co. Ltd. develops and manufactures radiopharmaceuticals. The company is based in Suzhou, China. | Health Technology |
| Suzhou Bionovogene Biotech Co. Ltd. | |
| Shanghai Kangjing Bioscience Co. Ltd. | |
| Suzhou Oncoimmune Co. Ltd. | |
Suzhou PANOMIX Biomedical Tech Co., Ltd.
Suzhou PANOMIX Biomedical Tech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Panomik Biomedical Technology Co. Ltd. provides metabolomics testing and analysis services. The company is located in China. | Commercial Services |
